U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
Torie Bosch is the First Opinion editor at STAT. In recent years, people are increasingly blaming perimenopause for a constellation of symptoms: weight gain, hair loss, brain fog. But does the ...
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a ...
For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...
An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results